These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 33180651)

  • 1. The effect of sex on responses to influenza vaccines.
    Denly L
    Hum Vaccin Immunother; 2021 May; 17(5):1396-1402. PubMed ID: 33180651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex-based biology and the rational design of influenza vaccination strategies.
    Klein SL; Pekosz A
    J Infect Dis; 2014 Jul; 209 Suppl 3(Suppl 3):S114-9. PubMed ID: 24966191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is there a difference in the immune response, efficacy, effectiveness and safety of seasonal influenza vaccine in males and females? - A systematic review.
    Tadount F; Doyon-Plourde P; Rafferty E; MacDonald S; Sadarangani M; Quach C
    Vaccine; 2020 Jan; 38(3):444-459. PubMed ID: 31711676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and immunogenicity of seasonal trivalent inactivated influenza vaccines in pregnant women.
    Munoz FM; Jackson LA; Swamy GK; Edwards KM; Frey SE; Stephens I; Ault K; Winokur P; Petrie CR; Wolff M; Patel SM; Keitel WA
    Vaccine; 2018 Dec; 36(52):8054-8061. PubMed ID: 30416018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and immunogenicity of the novel seasonal preservative- and adjuvant-free influenza vaccine: Blind, randomized, and placebo-controlled trial.
    Sarsenbayeva G; Volgin Y; Kassenov M; Issagulov T; Bogdanov N; Sansyzbay A; Abitay R; Nurpeisova A; Sagymbay A; Koshemetov Z; Stukova M; Buzitskaya Z; Кulmagambetov I; Karabayeva D; Davlyatshin T; Khairullin B
    J Med Virol; 2018 Jan; 90(1):41-49. PubMed ID: 28842994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and Immunogenicity of a Recombinant Influenza Vaccine: A Randomized Trial.
    Dunkle LM; Izikson R; Patriarca PA; Goldenthal KL; Cox M; Treanor JJ
    Pediatrics; 2018 May; 141(5):. PubMed ID: 29610401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized Comparison of Immunogenicity and Safety of Quadrivalent Recombinant Versus Inactivated Influenza Vaccine in Healthy Adults 18-49 Years of Age.
    Dunkle LM; Izikson R; Patriarca PA; Goldenthal KL; Muse D; Cox MMJ
    J Infect Dis; 2017 Dec; 216(10):1219-1226. PubMed ID: 28968871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex-specific patterns of gene expression following influenza vaccination.
    Wen F; Guo J; Li Z; Huang S
    Sci Rep; 2018 Sep; 8(1):13517. PubMed ID: 30202120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity of Influenza Vaccines: Evidence for Differential Effect of Secondary Vaccination on Humoral and Cellular Immunity.
    Rosendahl Huber SK; Hendriks M; Jacobi RHJ; van de Kassteele J; Mandersloot-Oskam JC; van Boxtel RAJ; Wensing AMJ; Rots NY; Luytjes W; van Beek J
    Front Immunol; 2018; 9():3103. PubMed ID: 30761157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seasonal influenza vaccines.
    Fiore AE; Bridges CB; Cox NJ
    Curr Top Microbiol Immunol; 2009; 333():43-82. PubMed ID: 19768400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and immunogenicity of a seasonal quadrivalent influenza vaccine (GC3110A) in healthy participants aged ≥ 65 years.
    Kim TH; Choi JH; Park SH; Yoo JH; Lee DG; Choi SM; Kim YR; Lee MS; Choo EJ; Choi HJ
    Vaccine; 2021 Jun; 39(27):3621-3625. PubMed ID: 33992436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity and safety of inactivated quadrivalent influenza vaccine in adults: A systematic review and meta-analysis of randomised controlled trials.
    Moa AM; Chughtai AA; Muscatello DJ; Turner RM; MacIntyre CR
    Vaccine; 2016 Jul; 34(35):4092-4102. PubMed ID: 27381642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy, effectiveness, and immunogenicity of influenza vaccines in Africa: a systematic review.
    Lindsey BB; Armitage EP; Kampmann B; de Silva TI
    Lancet Infect Dis; 2019 Apr; 19(4):e110-e119. PubMed ID: 30553695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy, immunogenicity, and safety evaluation of an MF59-adjuvanted quadrivalent influenza virus vaccine compared with non-adjuvanted influenza vaccine in children: a multicentre, randomised controlled, observer-blinded, phase 3 trial.
    Vesikari T; Kirstein J; Devota Go G; Leav B; Ruzycky ME; Isakov L; de Bruijn M; Oberye J; Heijnen E
    Lancet Respir Med; 2018 May; 6(5):345-356. PubMed ID: 29631857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cumulative clinical experience with MF59-adjuvanted trivalent seasonal influenza vaccine in young children.
    Patel SS; Bizjajeva S; Lindert K; Heijnen E; Oberye J
    Int J Infect Dis; 2019 Aug; 85S():S26-S38. PubMed ID: 31096055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety, immunogenicity, and lot-to-lot consistency of a quadrivalent inactivated influenza vaccine in children, adolescents, and adults: A randomized, controlled, phase III trial.
    Cadorna-Carlos JB; Nolan T; Borja-Tabora CF; Santos J; Montalban MC; de Looze FJ; Eizenberg P; Hall S; Dupuy M; Hutagalung Y; Pépin S; Saville M
    Vaccine; 2015 May; 33(21):2485-92. PubMed ID: 25843270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influenza vaccination in immunocompromised populations: Strategies to improve immunogenicity.
    Caldera F; Mercer M; Samson SI; Pitt JM; Hayney MS
    Vaccine; 2021 Mar; 39 Suppl 1():A15-A23. PubMed ID: 33422377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine effectiveness of live attenuated and trivalent inactivated influenza vaccination in 2010/11 to 2015/16: the SIVE II record linkage study.
    Simpson CR; Lone NI; Kavanagh K; Englishby T; Robertson C; McMenamin J; Wissman BV; Vasileiou E; Butler CC; Ritchie LD; Gunson R; Schwarze J; Sheikh A
    Health Technol Assess; 2020 Dec; 24(67):1-66. PubMed ID: 33256892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of age and recent influenza vaccination history on the immunogenicity and efficacy of 2009-10 seasonal trivalent inactivated influenza vaccination in children.
    Ng S; Ip DK; Fang VJ; Chan KH; Chiu SS; Leung GM; Peiris JS; Cowling BJ
    PLoS One; 2013; 8(3):e59077. PubMed ID: 23554974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity and safety of inactivated influenza vaccines in primed populations: a systematic literature review and meta-analysis.
    Beyer WE; Nauta JJ; Palache AM; Giezeman KM; Osterhaus AD
    Vaccine; 2011 Aug; 29(34):5785-92. PubMed ID: 21624411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.